Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment

This publication has 18 references indexed in Scilit:

• Prognostic factors in human primary breast cancer: Comparison of c-myc and HER2/neu amplification
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• Clinical breast cancer, new developments in selection and endocrine treatment of patients
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
  Journal of Clinical Oncology, 1992
• Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
  Breast Cancer Research and Treatment, 1992
• HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
  Journal of Clinical Oncology, 1992
• Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptors
  European Journal Of Cancer, 1992
• Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer
  The Lancet, 1992
• Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis
  British Journal of Cancer, 1991
• Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer
  European Journal of Cancer and Clinical Oncology, 1990
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958